<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mes</journal-id><journal-title-group><journal-title xml:lang="ru">Экстремальная биомедицина</journal-title><trans-title-group xml:lang="en"><trans-title>Extreme Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">3033-8964</issn><issn pub-type="epub">3033-8972</issn><publisher><publisher-name>Centre for Strategic Planning of the Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47183/mes.2022.011</article-id><article-id custom-type="elpub" pub-id-type="custom">mes-198</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНОЕ ИССЛЕДОВАНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Оценка влияния пандемии COVID-19 на общий коэффициент смертности населения Озерского городского округа</article-title><trans-title-group xml:lang="en"><trans-title>Evaluation of the impact of COVID-19 pandemic on overall mortality in Ozyorsk urban district</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Осипов</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Osipov</surname><given-names>M. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михаил Викторович Осипов</p><p>Озерское шоссе, д. 19/1, к. 108, г. Озерск, 456780</p></bio><bio xml:lang="en"><p>Mikhail V. Osipov</p><p>Ozyorskoe shosse 19/1, k. 108, Ozyorsk, 456780</p></bio><email xlink:type="simple">osipov@subi.su</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Соколова</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sokolova</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кушнир</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kushnir</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Южно-Уральский институт биофизики Федерального медико-биологического агентства</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Southern Urals Biophysics Institute of the Federal Medical Biological Agency</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Клиническая больница «РЖД-Медицина»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Clinical Hospital “RZhD-Medicine”</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>28</day><month>10</month><year>2024</year></pub-date><volume>24</volume><issue>2</issue><fpage>74</fpage><lpage>80</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Осипов М.В., Соколова В.А., Кушнир А.С., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Осипов М.В., Соколова В.А., Кушнир А.С.</copyright-holder><copyright-holder xml:lang="en">Osipov M.V., Sokolova V.A., Kushnir A.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.extrememedicine.ru/jour/article/view/198">https://www.extrememedicine.ru/jour/article/view/198</self-uri><abstract><p>Пандемия COVID-19, объявленная Всемирной организацией здравоохранения в марте 2020 г., обусловила необходимость оценки потенциального демографического ущерба для населения. Целью работы было провести ретроспективный анализ изменения демографической ситуации в Озерском городском округе, расположенном вблизи предприятия атомной промышленности ПО «Маяк». На основе опубликованных в открытом доступе демографических данных было ретроспективно проанализировано изменение численности населения за десятилетний период. Уровень общей смертности в 2020 г. сравнивался с каждым предыдущим годом в течение исследуемого периода для оценки величины отклонения уровня смертности от его прогнозируемого значения. Оценка влияния пандемии COVID-19 на демографический статус Озерского городского округа выполнялась с использованием грубого показателя общей смертности. Показано статистически значимое повышение уровня общей смертности в 2020 г. по сравнению с его ожидаемой оценкой на 19%. Абсолютный избыток общей смертности, отнесенный к влиянию пандемии, составил 13,4%. Ожидаемое число избыточных случаев смерти в результате заболевания COVID-19 как основной причины смерти составило 60 (4,2%). Пандемия COVID-19 оказала статистически значимое негативное влияние на демографический статус Озерского городского округа, однако ее влияние на общую смертность не было превалирующим.</p></abstract><trans-abstract xml:lang="en"><p>COVID-19 pandemic announced by World Health Organization in March 2020 raised concern on potential demographic losses. This retrospective study was aimed to analyze the pandemic-related changes in the demographic status of the Ozyorsk urban district located close to the nuclear industry facility — the “Mayak” Production Association. Population changes in the Ozyorsk urban district over the last decade were analyzed based on the open-access demographic data. The impact of the COVID-19 pandemic on the demographic status of the Ozyorsk urban district was assessed using the crude overall mortality rates. Comparison of the overall mortality rates has been performed between 2020 and each previous year to assess the deviation of mortality from the forecasted value. The overall mortality rate in 2020 has been found increased significantly by 19%. Excess mortality attributed to the impact of the pandemic was 13.4%. The expected absolute number of excess deaths from COVID-19 being the main cause of death was 60 (4.2%). The COVID-19 pandemic had a significant negative impact on the demographic status of the Ozyorsk urban district; however, the role of COVID-19-associated deaths in overall mortality was not predominant.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>пандемия</kwd><kwd>коронавирусная инфекция</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>показатели общей смертности</kwd><kwd>Озерск</kwd></kwd-group><kwd-group xml:lang="en"><kwd>pandemic</kwd><kwd>coronavirus infection</kwd><kwd>COVID-19</kwd><kwd>SARS-CoV-2</kwd><kwd>population changes</kwd><kwd>mortality rate</kwd><kwd>Ozyorsk</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Авторы выражают благодарность научному сотруднику отдела эпидемиологии Южно-Уральского института биофизики, к. м. н.  Ю. В. Царевой за помощь в обсуждении результатов исследования.</funding-statement><funding-statement xml:lang="en">The authors would like to express their appreciation to Yulia V. Tzareva, PhD, research fellow at the Department of Epidemiology, Southern Urals Biophysics Institute, for discussing the study results.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020; 508: 254–66. DOI: 10.1016/j.cca.2020.05.044.</mixed-citation><mixed-citation xml:lang="en">Lotfi M, Hamblin MR, Rezaei N. COVID-19: Transmission, prevention, and potential therapeutic opportunities. Clin Chim Acta. 2020; 508: 254–66. DOI: 10.1016/j.cca.2020.05.044.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Müller O, Neuhann F, Razum O. Epidemiologie und Kontrollma ß nahmen bei COVID-19 [Epidemiology and control of COVID-19]. Dtsch Med Wochenschr. 2020; 145 (10): 670–74. DOI: 10.1055/a-1162-1987.</mixed-citation><mixed-citation xml:lang="en">Müer O, Neuhann F, Razum O. Epidemiologie und Kontrollma ß nahmen bei COVID-19 [Epidemiology and control of COVID-19]. Dtsch Med Wochenschr. 2020; 145 (10): 670–74. DOI: 10.1055/a-1162-1987.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Modig K, Ahlbom A, Matthews A. COVID-19 — deaths and analysis. Lakartidningen. 2020; 117: F3XL. PMID: 32365212.</mixed-citation><mixed-citation xml:lang="en">Modig K, Ahlbom A, Matthews A. COVID-19 — deaths and analysis. Lakartidningen. 2020; 117: F3XL. PMID: 32365212.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Lai CC, Shih TP, Ko WC. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55 (3): 105924. DOI: 10.1016/j.ijantimicag.2020.105924.</mixed-citation><mixed-citation xml:lang="en">Lai CC, Shih TP, Ko WC. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55 (3): 105924. DOI: 10.1016/j.ijantimicag.2020.105924.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Ensheng D, Hongru D, Lauren G. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases. 2020; 20 (5): 533–34. DOI: 10.1016/S1473-3099(20)30120-1.</mixed-citation><mixed-citation xml:lang="en">Ensheng D, Hongru D, Lauren G. An interactive web-based dashboard to track COVID-19 in real time. The Lancet Infectious Diseases. 2020; 20 (5): 533–34. DOI: 10.1016/S1473-3099(20)30120-1.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Новосёлов В. Н., Носач Ю. Ф., Ентяков Б. Н. Атомное сердце России. Челябинск: Изд-во «Автограф», 2014; 528 с.</mixed-citation><mixed-citation xml:lang="en">Novoselov VN, Nosach YuF, Entyakov BN. Atomnoe serdce Rossii. Chelyabinsk: Izd-vo «Avtograf», 2014; 528 s. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральная целевая программа «Обеспечение ядерной и радиационной безопасности на 2016–2020 годы и на период до 2030 года». Доступно по ссылке (дата обращения 22.02.2022): http://фцп-ярб2030.рф/about/overview/.</mixed-citation><mixed-citation xml:lang="en">Federal'naya celevaya programma «Obespechenie yadernoj i radiacionnoj bezopasnosti na 2016–2020 gody i na period do 2030 goda». Dostupno po ssylke (data obrashheniya 22.02.2022): http://fcp-yarb2030.rf/about/overview/. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Драпкина О. М., Самородская И. В., Сивцева М. Г., Какорина Е. П., Брико Н. И., Черкасов С. Н. и др. Методические аспекты оценки заболеваемости, распространенности, летальности и смертности при COVID-19. Кардиоваскулярная терапия и профилактика. 2020; 19 (3): 302–09. DOI:10.15829/1728-8800-2020-2585.</mixed-citation><mixed-citation xml:lang="en">Drapkina OM, Samorodskaya IV, Sivceva MG, Kakorina EP, Briko NI, Cherkasov SN, i dr. Metodicheskie aspekty ocenki zabolevaemosti, rasprostranennosti, letal'nosti i smertnosti pri COVID-19. Kardiovaskulyarnaya terapiya i profilaktika. 2020; 19 (3): 302–09. DOI:10.15829/1728-8800-2020-2585. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. The Lancet. 2020; 395: 1014–5.</mixed-citation><mixed-citation xml:lang="en">Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. The Lancet. 2020; 395: 1014–5.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Дружинин П. В., Молчанова Е. В. Смертность населения российских регионов в условиях пандемии COVID-19. Регионология. 2021; 29 (3): 666–85. DOI: 10.15507/24131407.116.029.202103.666-685.</mixed-citation><mixed-citation xml:lang="en">Druzhinin PV, Molchanova EV. Smertnost' naseleniya rossijskix regionov v usloviyax pandemii COVID-19. Regionologiya. 2021; 29 (3): 666–85. DOI: 10.15507/24131407.116.029.202103.666-685. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Lifshits ML, Neklyudova NP. COVID-19 mortality rate in Russian regions: forecasts and reality. R-economy. 2020; 6 (3): 171–82. DOI: 10.15826/recon.2020.6.3.015.</mixed-citation><mixed-citation xml:lang="en">Lifshits ML, Neklyudova NP. COVID-19 mortality rate in Russian regions: forecasts and reality. R-economy. 2020; 6 (3): 171–82. DOI: 10.15826/recon.2020.6.3.015.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Дружинин П. В., Молчанова Е. В., Подлевских Ю. Л. Влияние пандемии Covid-19 на смертность населения российских регионов. Труды Карельского научного центра РАН. 2021; 7: 116–128. DOI: 10.17076/them1421.</mixed-citation><mixed-citation xml:lang="en">Druzhinin PV, Molchanova EV, Podlevskikh YuL. Vliyanie pandemii Covid-19 na smertnost' naseleniya rossijskix regionov. Trudy Karel'skogo nauchnogo centra RAN. 2021; 7: 116–128. DOI: 10.17076/them1421. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Всемирная организация здравоохранения (ВОЗ). Оценка показателей смертности от Covid-19. Доступно по ссылке (дата обращения 22.02.2022): https://www.who.int/news-room/commentaries/detail/estimating-mortality-from-covid-19.</mixed-citation><mixed-citation xml:lang="en">Vsemirnaya organizaciya zdravooxraneniya (VOZ). Ocenka pokazatelej smertnosti ot Covid-19. Dostupno po ssylke (data obrashheniya 22.02.2022): https://www.who.int/news-room/commentaries/detail/estimating-mortality-from-covid-19. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323 (20): 2052–9. DOI: 10.1001/jama.2020.6775.</mixed-citation><mixed-citation xml:lang="en">Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area. JAMA. 2020; 323 (20): 2052–9. DOI: 10.1001/jama.2020.6775.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323 (16): 1574–81. DOI: 10.1001/jama.2020.5394.</mixed-citation><mixed-citation xml:lang="en">Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. COVID-19 Lombardy ICU Network. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323 (16): 1574–81. DOI: 10.1001/jama.2020.5394.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Obesnyuk VF. Group health risk parameters in a heterogeneous cohort. Indirect assessment as per events taken in dynamics. Health Risk Analysis. 2021; 2: 17–32. DOI: 10.21668/health.risk/2021.2.02.eng.</mixed-citation><mixed-citation xml:lang="en">Obesnyuk VF. Group health risk parameters in a heterogeneous cohort. Indirect assessment as per events taken in dynamics. Health Risk Analysis. 2021; 2: 17–32. DOI: 10.21668/health.risk/2021.2.02.eng.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Паспорт Озёрского городского округа. Доступно по ссылке (дата обращения 22.02.2022): http://ozerskadm.ru/regulatory/passport/.</mixed-citation><mixed-citation xml:lang="en">Pasport Ozyorskogo gorodskogo okruga. Dostupno po ssylke (data obrashheniya 22.02.2022): http://ozerskadm.ru/regulatory/passport/. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Флетчер Р., Флетчер С., Вагнер Э. Клиническая эпидемиология. Основы доказательной медицины. М.: Изд-во «Медиа Сфера», 1998; 352 с.</mixed-citation><mixed-citation xml:lang="en">Fletcher R, Fletcher S, Vagner Eh. Klinicheskaya ehpidemiologiya. Osnovy dokazatel'noj mediciny. M.: Izd-vo «Media Sfera», 1998; 352 s. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Мерков А. М, Сухаребский Л. М. Статистика на службе народного здоровья. М.: Изд-во «Статистика», 1968; 48 с.</mixed-citation><mixed-citation xml:lang="en">Merkov AM, Suxarebskij LM. Statistika na sluzhbe narodnogo zdorov'ya. M.: Izd-vo «Statistika», 1968; 48 s. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Abramson, JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives &amp; Innovations. 2011; 8 (1). DOI: 10.1186/1742-5573-8-1.</mixed-citation><mixed-citation xml:lang="en">Abramson, JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiologic Perspectives &amp; Innovations. 2011; 8 (1). DOI: 10.1186/1742-5573-8-1.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Reality check on reproducibility. Nature. 2016; 533 (7604): 437. DOI: 10.1038/533437a.</mixed-citation><mixed-citation xml:lang="en">Reality check on reproducibility. Nature. 2016; 533 (7604): 437. DOI: 10.1038/533437a.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Регионы России. Социально-экономические показатели. Статистический сборник. 2020. Доступно по ссылке (дата обращения 22.02.2022): https://gks.ru/bgd/regl/b20_14p/Main.htm.</mixed-citation><mixed-citation xml:lang="en">Regiony Rossii. Social'no-ehkonomicheskie pokazateli. Statisticheskij sbornik. 2020. Dostupno po ssylke (data obrashheniya 22.02.2022): https://gks.ru/bgd/regl/b20_14p/Main.htm. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Федеральная служба государственной статистики «Росстат». Доступно по ссылке (дата обращения 22.02.2022): https://rosstat.gov.ru/storage/mediabank/TwbjciZH/edn12-2020.html.</mixed-citation><mixed-citation xml:lang="en">Federal'naya sluzhba gosudarstvennoj statistiki «Rosstat». Dostupno po ssylke (data obrashheniya 22.02.2022): https://rosstat.gov.ru/storage/mediabank/TwbjciZH/edn12-2020.html. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Здравоохранение в России. Стат. сб. M.: Изд-во «Росстат», 2021; 171 с.</mixed-citation><mixed-citation xml:lang="en">Zdravooxranenie v Rossii. Stat. sb. M.: Izd-vo «Rosstat», 2021; 171 s. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Blagosklonny MV. From causes of aging to death from COVID-19. Aging (Albany NY). 2020; 12 (11): 10004–21. DOI: 10.18632/aging.103493.</mixed-citation><mixed-citation xml:lang="en">Blagosklonny MV. From causes of aging to death from COVID-19. Aging (Albany NY). 2020; 12 (11): 10004–21. DOI: 10.18632/aging.103493.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55 (5): 2000547. DOI: 10.1183/13993003.00547-2020.</mixed-citation><mixed-citation xml:lang="en">Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. China Medical Treatment Expert Group for COVID-19. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. 2020; 55 (5): 2000547. DOI: 10.1183/13993003.00547-2020.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Bong CL, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries. Anesth Analg. 2020; 131 (1): 86–92. DOI: 10.1213/ANE0000000000004846.</mixed-citation><mixed-citation xml:lang="en">Bong CL, Brasher C, Chikumba E, McDougall R, Mellin-Olsen J, Enright A. The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries. Anesth Analg. 2020; 131 (1): 86–92. DOI: 10.1213/ANE0000000000004846.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Herby J, Joung L, Hanke S. A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Studies in Applied Economics. 2022; 200: 1–61.</mixed-citation><mixed-citation xml:lang="en">Herby J, Joung L, Hanke S. A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Studies in Applied Economics. 2022; 200: 1–61.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
